Wellington Management Group LLP Alnylam Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$551 Billion
Q1 2024

A detailed history of Wellington Management Group LLP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 7,209,005 shares of ALNY stock, worth $1.75 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares

7,209,005

Holding current value

$1.75 Billion

% of portfolio

0.2%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $1.06 Billion - $1.43 Billion	7,209,005 New	7,209,005 $1.08 Billion
Q4 2023 Feb 12, 2024	BUY	$151.41 - $196.57 $1.09 Billion - $1.42 Billion	7,214,198 New	7,214,198 $1.38 Billion
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $62.2 Million - $77 Million	364,021 Added 6.0%	6,431,814 $1.14 Billion
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $15.9 Million - $18.2 Million	-85,984 Reduced 1.4%	6,067,793 $1.15 Billion
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $14.7 Million - $18.9 Million	-80,309 Reduced 1.29%	6,153,777 $1.23 Billion

Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $51.9 Million - $67.5 Million	279,793 Added 4.7%	6,234,086 $1.48 Billion
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $19.6 Million - $32.8 Million	141,423 Added 2.43%	5,954,293 $1.19 Billion
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $147 Million - $207 Million	-1,221,617 Reduced 17.37%	5,812,870 $848 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $24.2 Million - $33.1 Million	190,057 Added 2.78%	7,034,487 $1.15 Billion
Q4 2021 Feb 11, 2022	SELL	$159.56 - $209.29 $84 Million - $110 Million	-526,642 Reduced 7.14%	6,844,430 $1.16 Billion
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $307 Million - $375 Million	-1,807,417 Reduced 19.69%	7,371,072 $1.39 Billion
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $3.93 Million - $5.4 Million	30,539 Added 0.33%	9,178,489 $1.56 Billion
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $115 Million - $160 Million	-908,990 Reduced 9.04%	9,147,950 $1.29 Billion
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $9.91 Million - $11.8 Million	-80,586 Reduced 0.79%	10,056,940 $1.31 Billion
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $40.5 Million - $55.3 Million	-334,201 Reduced 3.19%	10,137,526 $1.48 Billion
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $189 Million - $284 Million	-1,815,051 Reduced 14.77%	10,471,727 $1.55 Billion
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $186 Million - $268 Million	-1,999,696 Reduced 14.0%	12,286,778 $1.34 Billion
Q4 2019 Feb 11, 2020	BUY	$74.51 - $124.23 $1.06 Billion - $1.77 Billion	14,286,474 New	14,286,474 $1.65 Billion

Others Institutions Holding ALNY

# of Institutions

584

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Alnylam Pharmaceuticals, Inc. Transaction History